Cardiovascular disease prevention: cardiovascular risk assessment for people newly diagnosed with hypertension or T2DM
Update information
Minor changes since publication
August 2025: We removed reference to a full formal risk assessment using the QRISK3 tool as being a national priority for quality improvement, from the rationale of this indicator. This was a result of a major update to NICE's quality standard on cardiovascular risk assessment and lipid modification in July 2025.
April 2024: We updated links to source guidance NG238 and added expected population size.
ISBN: 978-1-4731-6036-1